Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q2 2014 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PALO ALTO NETWORKS INC | 23 | Q2 2024 | 7.1% |
ASCENDIS PHARMA AS SPONSORED ADR | 23 | Q2 2024 | 7.0% |
GODADDY INC CL A | 23 | Q2 2024 | 5.5% |
EXACT SCIENCES CORP | 23 | Q2 2024 | 5.7% |
NUTANIX INC CL A | 22 | Q1 2024 | 5.9% |
AFFILIATED MANAGERS GROUP INC | 22 | Q1 2024 | 6.4% |
SPLUNK INC | 20 | Q3 2023 | 7.2% |
PACIRA PHARMACEUTICALS INC | 18 | Q1 2023 | 5.2% |
FIVE BELOW INC | 18 | Q2 2024 | 5.0% |
VAIL RESORTS INC | 18 | Q4 2023 | 4.4% |
View Spyglass Capital Management LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
13F-HR | 2024-08-14 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13G/A | 2022-11-14 |
SC 13G/A | 2022-11-14 |
View Spyglass Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.